News and Trends 16 Jan 2025Top biotech deals of December 2024 The month of December saw a variety of biotech deals take place to advance therapies across different stages in development. January 16, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 10 Jan 2025The in vivo revolution: How Interius, Umoja, and Vyriad are transforming CAR-T cell therapy A U.S. trial of an in vivo CAR gene therapy has expanded to Europe, marking the first-ever trial of its kind in the region. January 10, 2025 - 5 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 9 Jan 2025Von Willebrand disease: Star Therapeutics, Chugai and Band Therapeutics are breaking new ground Explore advances in von Willebrand disease treatment, including Star Therapeutics’ VGA039, and other key players in the space. January 9, 2025 - 7 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 2 Jan 2025A surge in deals: GSK bets on ADC, neuro and fibrotic diseases to bolster drug development Last month saw a number of alliances forming in a range of therapeutic spaces but there has been one serial collaborator that stands out – GSK. January 2, 2025 - 6 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 12 Dec 2024Top biotech deals of November 2024 November has seen a variety of biotech deals take place to advance therapies across different stages in development. December 12, 2024 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 29 Nov 2024Trump’s healthcare picks: Who they are and what they mean for the biopharma industry Trump’s nominees for top healthcare roles have sparked significant debate. So, what do their appointments signal for the future of healthcare in the U.S.? November 29, 2024 - 11 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 25 Nov 2024Evotec on the brink of acquisition: At what cost for the biotech industry? As the signs point toward a potential Evotec acquisition, delve into what it could represent for the European biotech landscape. November 25, 2024 - 8 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 4 Nov 2024Top biotech deals of October 2024 Discover the major biotech partnerships, collaborations and mergers and acquisitions that made headlines in October 2024. November 4, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 31 Oct 2024Halloween biotech stories: Unveiling scientists’ worst fears What are scientists scared of? Delve into three biotech sci-fi-inspired scenarios that might make you fear progress. October 31, 2024 - 15 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 24 Oct 2024Fighting severe epilepsies: A new era for Dravet syndrome treatment? Delve into the field of severe epilepsies as new treatments for Dravet syndrome are progressing through the pipeline. October 24, 2024 - 10 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 23 Oct 2024RNA editing in humans: the race begins with first successful trial Wave Life Sciences achieves RNA editing in the clinic, crossing a major milestone in the space. October 23, 2024 - 6 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 21 Oct 2024Turning back time with cellular reprogramming: Shift raises $16 million in seed funding As Shift Bioscience raises $16 million in seed funding, delve into the field of cellular reprogramming to tackle age-related diseases. October 21, 2024 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email